{"id":782,"date":"2026-07-21T13:38:08","date_gmt":"2026-07-21T11:38:08","guid":{"rendered":"https:\/\/www.novacos-law.com\/en\/?p=782"},"modified":"2026-07-21T13:38:08","modified_gmt":"2026-07-21T11:38:08","slug":"press-release-17-july-2026-novacos-advises-ardian-on-the-sale-of-the-gba-group-to-bridgepoint","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2026\/press-release-17-july-2026-novacos-advises-ardian-on-the-sale-of-the-gba-group-to-bridgepoint\/","title":{"rendered":"Press release 17 July 2026: NOVACOS advises Ardian on the sale of the GBA Group to Bridgepoint"},"content":{"rendered":"

Du\u0308sseldorf, 17 July 2026 \u2013 NOVACOS has provided Ardian with comprehensive advice\u00a0on pharmaceutical law and regulatory matters in connection with the sale of its majority\u00a0stake in the GBA Group (\u201cGBA\u201d), an international provider of life sciences and\u00a0laboratory analytics services, to Bridgepoint. Milbank LLP led the transaction on the\u00a0seller\u2019s side.<\/p>\n

Please see the full press release here<\/a>…<\/p>\n","protected":false},"excerpt":{"rendered":"

Du\u0308sseldorf, 17 July 2026 \u2013 NOVACOS has provided Ardian with comprehensive advice\u00a0on pharmaceutical law and regulatory matters in connection with the sale of its majority\u00a0stake in the GBA Group (\u201cGBA\u201d), an international provider of life sciences and\u00a0laboratory analytics services, to Bridgepoint. Milbank LLP led the transaction on the\u00a0seller\u2019s side. Please see the full press release […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-782","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t